Anti-BRMS-1抗體,乳腺癌轉移抑制基因1抗體免疫實驗產(chǎn)品詳細資料
產(chǎn)品編號 BYK-1015R
英文名稱 BRMS-1
中文名稱 乳腺癌轉移抑制基因1抗體
別 名 AV003220;AW554636;Breast cancer metastasis suppressor 1 ; BRMS1; BRMS 1; DKFZp564A063;MGC95128; BRMS1_HUMAN.
研究領域 腫瘤 免疫學
分 子 量 28kDa
細胞定位 細胞核 細胞漿
抗體來源 Mouse or Rabbit
克隆類型 Monoclonal or Polyclonal
產(chǎn)品應用 WB、ELISA、IHC-P、IHC-F、Flow-Cyt、IF、IP、ICC 此產(chǎn)品應用不做依據(jù),具體產(chǎn)品應用與實驗稀釋比請!
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
性 狀 Lyophilized or Liquid
濃 度 1mg/1ml
亞 型 IgG
純化方法 affinity purified by Protein G
儲 存 液 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
保存條件 Store at -20℃ for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20℃. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4℃.
Anti-BRMS-1抗體,乳腺癌轉移抑制基因1抗體免疫實驗產(chǎn)品介紹
Breast cancer metastasis-suppressor 1 (BRMS1) is 246 amino acid protein that acts as a mediator of metastasis suppression in several types of cancer including ovarian, lung, bladder, and murine mammary. BRMS1 mRNA is expressed in various tissues, including ovary, prostate, testis, and colon, but the protein is primarily detected in term placenta. BRMS1 suppresses metastasis without inhibiting tumorigenicity by modifying several metastasis-associated phenotypes. BRMS1 may participate in transcriptional regulation by binding to the mSin3/histone deacetylase complex. The expression of BRMS1 in certain cells increases connexin Cx43 expression and reduces connexin Cx32 expression. This produces a gap junction that increases intercellular communication, similar to those found in normal breast tissue. BRMS1 is stabilized by Hsp90 and may inhibit NF-ⅹB activity.
此相關標記有:Alexa Fluor 350 標記、Alexa Fluor 488 標記、Alexa Fluor 555 標記、Alexa Fluor 647 標記、AP標記、APC標記、Biotin標記、Cy3標記、Cy5標記、Cy5.5標記、Cy7標記、FITC標記、Gold標記、HRP標記、PE標記、PE-Cy3標記、PE-CY5標記、PE-CY5.5標記、PE-CY7標記、RBITC標記
相關產(chǎn)品:
Anti-GPR135抗體,G蛋白偶聯(lián)受體GPR135蛋白抗體
Anti-GPR142抗體,G蛋白偶聯(lián)受體GPR142蛋白抗體
Anti-GPR176抗體,G蛋白偶聯(lián)受體GPR176蛋白抗體
Anti-GPR37L1抗體,G蛋白偶聯(lián)受體GPR37樣蛋白1抗體
Anti-GPR89A抗體,G蛋白偶聯(lián)受體GPR89A蛋白抗體
Anti-GPR91抗體,G蛋白偶聯(lián)受體GPR91蛋白抗體
Anti-GPRASP2抗體,G蛋白偶聯(lián)受體GPRSP2蛋白抗體
Anti-GPRC5C抗體,G蛋白偶聯(lián)受體GPRC5C蛋白抗體
Anti-GPS2抗體,G蛋白通路抑制物蛋白2抗體
Anti-GLS1抗體,*酶1/Glutaminase抗體
Anti-Galectin-3抗體,半乳糖凝集素3抗體
Anti-Ghrelin 28抗體,辛?;X腸肽抗體
Anti-GPI抗體,糖磷脂酰肌醇抗體
Anti-GGT2 light chain抗體,γ谷氨酰轉肽酶2輕鏈抗體
Anti-GGT5 light chain抗體,γ-谷氨酰轉肽酶5輕鏈抗體
Anti-GNPTAB抗體,溶酶體累積病相關蛋白/口吃相關蛋白抗體
Anti-GPAT4抗體,甘油?;D移酶4抗體
Anti-GALNT14抗體,GalNAc-T14抗體
Anti-GREM2抗體,骨形態(tài)形成蛋白拮抗蛋白2抗體